武汉中帜生物科技股份有限公司

Wuhan Zhongzhi Biotechnologies Inc. is a high-tech enterprise specialized in the research and development, production and sales of innovative molecular technology-based diagnostic products. Our company has successfully developed a number of technology platforms, including multi-biotin signal amplification technology (MBSA), dual amplification technology (DAT), and RNA constant temperature amplification with gold probe chromatography (RGT). -DAT has been utilized in the development of RNA multiplex detection kits, including 7-plex respiratory pathogen detection kit and 3-plex enterovirus detection kit. -RGT has been applied into the development of single and multiplex RNA detection kits including FluA & FluB RNA dual detection kit and MP RNA detection kit. The whole detection process can be completed in 1 hour. In addition, the company has been developing new products, including detection kits of diarrhea-related pathogens and reproductive tract pathogens. The company will uphold the purpose of "improving the quality of diagnosis and treatment, care for life and health", focusing on multiplex and rapid detection of pathogen RNAs. ZhongZhi Bio now strive to serve the world clinical diagnosis marketing with high quality products. The goal of our company is to be one of world-class diagnostic product suppliers.